©The Author(s) 2020.
World J Gastrointest Surg. Feb 27, 2020; 12(2): 34-44
Published online Feb 27, 2020. doi: 10.4240/wjgs.v12.i2.34
Published online Feb 27, 2020. doi: 10.4240/wjgs.v12.i2.34
Table 3 Effect of statins on patient and tumour variables
| Demographic, clinical and pathological factors | Statin therapy use (n = 181) | No statin therapy use (n = 408) | P value |
| Age > 65 yr | 106 | 236 | 0.947 |
| Male gender | 119 | 270 | 0.827 |
| Synchronous presentation | 67 | 158 | 0.646 |
| Neutrophil-to-lymphocyte ratio ≥ 5 | 22 | 74 | 0.065 |
| Platelet-to-lymphocyte ratio ≥ 150 | 88 | 211 | 0.436 |
| Neo-adjuvant chemotherapy | 38 | 87 | 0.894 |
| Hemi-hepatectomy or more | 61 | 157 | 0.241 |
| Largest tumour size ≥ 5 cm | 53 | 127 | 0.615 |
| Solitary hepatic metastases | 91 | 203 | 0.973 |
| Steatosis - None | 127 | 299 | 0.634 |
| Lymphatic invasion | 16 | 50 | 0.215 |
| Perineural invasion | 13 | 20 | 0.276 |
| Vascular invasion | 88 | 176 | 0.246 |
| Biliary invasion | 62 | 119 | 0.238 |
| Resection margin R0 | 133 | 294 | 0.823 |
- Citation: Alabraba E, Ibrahim H, Olaru A, Cameron I, Gomez D, Group NHS. Retrospective cohort study of statin therapy effect on resected colorectal liver metastases. World J Gastrointest Surg 2020; 12(2): 34-44
- URL: https://www.wjgnet.com/1948-9366/full/v12/i2/34.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i2.34